PIPE 858
Alternative Names: PIPE-858Latest Information Update: 15 Dec 2023
At a glance
- Originator Pipeline Therapeutics
- Developer Contineum Therapeutics; University of California at San Francisco
- Class Small molecules
- Mechanism of Action Selective estrogen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Multiple sclerosis